by epionepainandspines | Oct 22, 2026 | Blog
Quick answer: Neck pain is common in people with migraine and can be a migraine symptom, a trigger, or a separate cervical problem. Newer research is exploring shared pain-processing mechanisms, including central sensitization, which may help explain why migraine,...
by epionepainandspines | Oct 22, 2026 | Blog
Quick answer: A knee joint injection places medication inside the joint, a genicular nerve block targets sensory nerves around the knee, and radiofrequency ablation uses energy to reduce pain signaling from selected nerves. They are not interchangeable, and the right...
by epionepainandspines | Oct 22, 2026 | Blog
Quick answer: Genicular nerve blocks can be performed with local anesthetic, and some clinicians add corticosteroid. A 2026 randomized placebo-controlled trial specifically examined whether adding steroid provides additional clinical value; the result should inform...
by epionepainandspines | Oct 22, 2026 | Blog
Quick answer: NaV1.8 inhibitors are a new class of pain medicines designed to reduce peripheral pain signaling without acting on opioid receptors. Suzetrigine (Journavx) was approved by the U.S. FDA in January 2025 for moderate-to-severe acute pain in adults; that...
by epionepainandspines | Oct 22, 2026 | Blog
Quick answer: Peripheral nerve stimulation (PNS) delivers electrical stimulation near a selected peripheral nerve to modulate pain signaling. It is being studied and used in selected neuropathic pain conditions, but candidacy depends on a clear pain target, prior...
